<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01720420</url>
  </required_header>
  <id_info>
    <org_study_id>T-174</org_study_id>
    <nct_id>NCT01720420</nct_id>
  </id_info>
  <brief_title>A Clinical Evaluation of NobelProcera Implant Bar Overdenture</brief_title>
  <official_title>A Clinical Evaluation of NobelProceraTM Implant Bar Overdenture in the Mandible or Maxilla on 4 NobelReplaceTM CC Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nobel Biocare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. Martin Vanselow Biometrie &amp; Statistik</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nobel Biocare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      AN OPEN 5-YEAR PROSPECTIVE, CLINICAL MULTI-CENTER STUDY on NobelProcera Implant Bar Titanium
      with Locator attachment and related Overdenture on 4 NobelReplace implants with conical
      connection (CC) in the mandible/maxilla.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study centers: 8 centers in 4 countries

      Objectives of the study:

      Primary Objective:

      To evaluate and compare the clinical marginal bone level change (MBL) around the
      NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture
      (fixed-removable) in the mandible with the clinical marginal bone level change (MBL) of the
      NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture
      (fixed-removable) in the maxilla for a period of 5 years.

      Secondary Objectives:

        1. To evaluate and compare the cumulative survival rate (CSR) of the NobelReplaceTM CC
           implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the
           mandible with the cumulative survival rate (CSR) of the NobelReplaceTM CC implants
           supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the maxilla for a
           period of 5 years.

        2. To evaluate and compare the cumulative survival rate (CSR) of NobelProceraTM Implant Bar
           Overdenture (fixed-removable) on four (4) NobelReplace CC implants in the mandible with
           the cumulative survival rate (CSR) of NobelProceraTM Implant Bar Overdenture
           (fixed-removable) on four (4) NobelReplace CC implants in the maxilla after 5 years.

        3. To evaluate the clinical behaviour (soft tissue behavior, clinical function, patient
           satisfaction, Quality of Life and prosthetic maintenance needs such as wear, chipping of
           denture teeth, need for exchange of attachment components) of NobelProceraTM Implant Bar
           Overdenture (fixed-removable) in the mandible and maxilla over 5 years of clinical
           function.

      Study design 5-year, open, prospective, clinical multi-center study.

      Number of subjects 76 (in total), 7-9 per center

      Patient population Adult female or male, at least 18 (or age of consent) and not older than
      70 years, suitable for treatment with implant supported bar overdentures in the edentulous
      mandible or maxilla.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MBL,marginal bone level change</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>To evaluate and compare the clinical marginal bone level change (change MBL)in relation to defined implant reference point and different time points in the maxilla and mandible(between baseline at implant insertion and follow-up time points at 1 month, 6 month, 1 year, 2 year, 3 year and 5 year after implant insertion) of observation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CSR implants</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>CSR in % of placed implants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CSR prosthetics</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>survival in % of placed final restorations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival Status</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>Gingival status(Silness and Loe 1963):0 = Normal gingiva surrounding crown/control tooth,1 = Mild inflammation,2 = Moderate inflammation.3 = Severe inflammation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Status of mucosa</measure>
    <time_frame>6 month, 1, 2, 3, 5 year,</time_frame>
    <description>0 = No keratinized mucosa.1 = Mucosa partially keratinized.2 = entire mucosa keratinized.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding tendency</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>(modified Sulcus Bleeding Index_mBI)(Mombelli):0 = No bleeding when a periodontal probe is passed along gingival margin adjacent to the implant.1 = Isolated bleeding spots visible. 2 = Blood forms a confluent red line on the margin 3 = Heavy or profuse bleeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque accumulation</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>modified Plaque Index (mPlI) (Mombelli):0 = No detectible plaque. 1 = Plaque only recognized by running a probe across the marginal surface of the implant. 2 = Plaque can be seen by the naked eye.3 = Abundance of soft matter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pocket depths</measure>
    <time_frame>6 month, 1, 2, 3, 5 year</time_frame>
    <description>Pocket depths measured around implants in millimeter (mm)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Edentulous</condition>
  <arm_group>
    <arm_group_label>Mandible</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maxilla</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NobelReplace CC, NobelProcera Implant Bar</intervention_name>
    <description>Implants titanium with conical connection, individualized titanium bar</description>
    <arm_group_label>Mandible</arm_group_label>
    <arm_group_label>Maxilla</arm_group_label>
    <other_name>NobelReplace CC implants</other_name>
    <other_name>NobelProcera Implant Bar Titanium</other_name>
    <other_name>Overdenture (lab-made)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is at least 18 years of age (or age of consent) and has passed secession
             of growth

          2. The subject is not older than 70 years

          3. Obtained informed consent from the subject

          4. Edentulous mandible or maxilla providing sufficient bone whereas removable
             NobelProceraTM Implant Bar Overdenture on four (4) implants is regarded as an
             appropriate treatment solution

          5. The subject has an osseous architecture enough to receive four implants and a
             sufficient amount of bone for placing in healed or extraction sites implants with a
             length of at least 10mm

          6. The implant site is free from infection and extraction remnants

          7. Implants will be placed in healed or extractions sites, defined as a site with 8 weeks
             of healing following tooth extraction, respectively 6 months after major bone
             augmentation or soft tissue grafting

          8. Good gingival / periodontal / periapical status of opposing teeth/implants

          9. The subject fulfills the prerequisite that a harmonic, stable occlusal relationship
             can be achieved with opposing natural teeth resp. fixed or removable opposing
             dentition (tooth or implant based

         10. The subjects as well as the implant site(s) fulfill the criteria for early loading (6
             weeks until 3 months after implant placement)

         11. The subject is in such a physical and mental condition that a 5-year follow-up period
             can be carried out without foreseeable problems

         12. The subject is available for the 5-year term of the investigation

         13. The subject is compliant with good oral hygiene

        Exclusion Criteria:

          1. The subject is not able to give her/his informed consent of participating

          2. Health conditions, which do not permit the surgical (including anesthesia) or
             restorative procedure

          3. Reason to believe that the treatment might have a negative effect on the subject's
             overall situation (psychiatric problems), as noted in subject records or in subject
             history

          4. Any disorders in the planned implant area such as previous tumors, chronic bone
             disease or previous irradiation in the head/neck area

          5. Alcohol or drug abuse as noted in subject records or in subject history

          6. Smoking of &gt;10 cigarettes/day

          7. Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of
             neglecting doctor's recommendations regarding treatment, food and alcohol intake

          8. Pathologic occlusion, e.g. severe bruxism or other destructive habits

          9. Lack of opposing dentition or unstable occlusion

         10. Ongoing infections, endodontic or periodontal problems in opposing teeth or implants

         11. Subject shows an unacceptable oral hygiene

         12. Subject has allergic or adverse reactions to the restorative material.

         13. Bone augmentation of more than 3mm vertical height performed less than 3 months prior
             to planned implant placement.

         14. Long-term bis-phosphonate therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido Heydecke, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poliklinik für Zahnärztliche Prothetik, University Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Pozzi, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rome, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugenio Romeo, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Ferrari, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Siena, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edoardo Stellini, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Padova, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nikolaus and Alexandra Behneke, Prof., Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Mainz, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katrin-Caroline Voigt</last_name>
    <phone>+41432115</phone>
    <phone_ext>840</phone_ext>
    <email>katrin.caroline.voigt@nobelbiocare.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guido Heydecke</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Heydecke, Prof</last_name>
      <phone>+4940741053267</phone>
      <email>g.heydecke@uke.de</email>
    </contact>
    <investigator>
      <last_name>Guido Heydecke, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nikolaus and Alexandra Behneke</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Behneke, Dr.</last_name>
      <phone>+49613117</phone>
      <phone_ext>7257</phone_ext>
      <email>alexandra.behneke@unimedizin-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Nikolaus Behneke, Prof</last_name>
      <phone>+49613117</phone>
      <phone_ext>7257</phone_ext>
      <email>nbehneke@unimedizin-mainz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Nikolaus Behneke, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra Behneke, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eugenio Romeo</name>
      <address>
        <city>Milan</city>
        <zip>20143</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugenio Romeo, Prof</last_name>
      <phone>+3925319004</phone>
      <email>eugenio.romeo@unimi.it</email>
    </contact>
    <investigator>
      <last_name>Eugenio Romeo, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edoardo Stellini</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edoardo Stellini, Prof</last_name>
      <phone>+39335284956</phone>
      <email>edoardo.stellini@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Edoardo Stellini, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alessandro Pozzi</name>
      <address>
        <city>Rome</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Pozzi, Prof</last_name>
      <phone>+39337871240</phone>
      <email>studiopozzi@me.com</email>
    </contact>
    <investigator>
      <last_name>Alessandro Pozzi, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marco Ferrari</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Ferrari, Prof</last_name>
      <phone>+39586892283</phone>
      <email>md3972@mclink.it</email>
    </contact>
    <investigator>
      <last_name>Marco Ferrari, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Switzerland</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2012</study_first_submitted>
  <study_first_submitted_qc>October 31, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2012</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>edentulous</keyword>
  <keyword>maxilla</keyword>
  <keyword>mandible</keyword>
  <keyword>dental implant</keyword>
  <keyword>bar</keyword>
  <keyword>overdenture</keyword>
  <keyword>Oral Health Impact Profile (OHIP)</keyword>
  <keyword>survival rate</keyword>
  <keyword>technical complications</keyword>
  <keyword>marginal bone level</keyword>
  <keyword>soft tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth, Edentulous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

